Kane Biotech Gains Key International Quality Certification
Company Announcements

Kane Biotech Gains Key International Quality Certification

Story Highlights

Kane Biotech (TSE:KNE) has released an update.

Kane Biotech Inc. has achieved ISO 13485:2016 MDSAP Quality Certification, allowing it to seek regulatory approval for its medical products in Canada, Australia, New Zealand, and Brazil. This certification, which acknowledges Kane’s commitment to quality and patient safety, is a significant step for the company as it aims to improve the quality of chronic wound care products and expand its portfolio in these international markets.

For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskKane Biotech Expands with New Distribution Deal
TipRanks Canadian Auto-Generated NewsdeskKane Biotech Initiates Global Wound Care Collaboration
TipRanks Canadian Auto-Generated NewsdeskKane Biotech to Showcase Wound Care Innovations
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App